These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6595931)

  • 1. Effect of combination therapy of specific active immunization and aclacinomycin-A on murine myeloid leukemia.
    Nara N; Jinnai I; Bessho M; Hirashima K
    Nihon Ketsueki Gakkai Zasshi; 1984 Sep; 47(6):1280-6. PubMed ID: 6595931
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of murine myeloid leukemia by aclacinomycin-A based on the dynamics of leukemic colony forming unit and normal hematopoietic stem cells.
    Nara N
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1324-32. PubMed ID: 6963084
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of established tumor by adoptive immunotherapy with specifically immune T cells.
    Greenberg PD; Cheever MA
    Surv Immunol Res; 1985; 4(4):283-96. PubMed ID: 3879738
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of aclacinomycin-A on murine leukemia.
    Nara N; Miyamoto T; Hirashima K; Momoi H
    Blood; 1982 Jul; 60(1):188-93. PubMed ID: 6952948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Ishii E; Matsuzaki A; Kato Y; Miyazaki S; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1297-9. PubMed ID: 3468729
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of N-methylacetamide and splenectomy on RF murine myeloid leukemia.
    Preisler H; Bjornsson S; Pavelic Z
    Leuk Res; 1979; 3(4):249-51. PubMed ID: 293455
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
    Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
    Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aclacinomycin inhibits suppressor cells in vivo and in vitro.
    Orbach-Arbouys S; Andrade-Mena CE; Berardet M; Mathe G
    Behring Inst Mitt; 1984 May; (74):258-61. PubMed ID: 6236791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of chalones in the therapy of leukemias].
    Bala IuM; Kovalevskaia NP
    Probl Gematol Pereliv Krovi; 1981 Dec; 26(12):12-6. PubMed ID: 6460236
    [No Abstract]   [Full Text] [Related]  

  • 10. Interleukin-12 (IL-12) gene therapy of leukemia: immune and anti-leukemic effects of IL-12-transduced hematopoietic progenitor cells.
    Gautam SC; Xu YX; Dumaguin M; Janakiraman N; Chapman RA
    Cancer Gene Ther; 2000 Jul; 7(7):1060-8. PubMed ID: 10917209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of splenectomy with polychemotherapy in the treatment of 15 chronic myeloid leukemia patients].
    Mendeleev IM; Berliner GB; Miasnikov AA; Polezheav IuN
    Ter Arkh; 1986; 58(9):84-8. PubMed ID: 3466393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental and clinical use of cell cultures in chronic myeloid leukemia].
    Burgaleta C; Soria H; Moreno T
    Sangre (Barc); 1984; 29(4-B):549-64. PubMed ID: 6393382
    [No Abstract]   [Full Text] [Related]  

  • 13. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
    Beck JD
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization in vitro to murine myeloblastic leukemia cells by xenogeneic immune RNA.
    Preisler HD; Jacobs SK
    J Natl Cancer Inst; 1979 Jan; 62(1):133-7. PubMed ID: 281568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake, efflux, and hydrolysis of aclacinomycin A in Friend leukemia cells.
    Fourcade A; Farhi JJ; Bennoun M; Tapiero H
    Cancer Res; 1982 May; 42(5):1950-4. PubMed ID: 6950813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
    Marie JP; Thevenin D; Zittoun R
    Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T cells tumor specific response exists in L615 leukemia mice: adoptive transfer in combination with cyclophosphamide.
    Zhang S; Zhang HJ; Wang HY; Wang Q; Li WF; Yu L
    Exp Oncol; 2004 Jun; 26(2):156-7. PubMed ID: 15273668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time pattern of antileukemic effect of graft-versus-host reaction in mice.
    Boranić M
    Transplant Proc; 1971 Mar; 3(1):394-6. PubMed ID: 4398494
    [No Abstract]   [Full Text] [Related]  

  • 19. Cloned helper and cytotoxic T lymphocytes as effector cells in adoptive immunotherapy of murine leukemia.
    Bookman MA; Horak E; de Graaf PW
    Prog Clin Biol Res; 1989; 288():141-9. PubMed ID: 2524069
    [No Abstract]   [Full Text] [Related]  

  • 20. IL-12 gene therapy of leukemia with hematopoietic progenitor cells without the toxicity of systemic IL-12 treatment.
    Xu YX; Gao X; Janakiraman N; Chapman RA; Gautam SC
    Clin Immunol; 2001 Feb; 98(2):180-9. PubMed ID: 11161974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.